Trademark Overview
On Thursday, November 13, 2025, a trademark application was filed for NADOX with the United States Patent and Trademark Office. The USPTO has given the NADOX trademark a serial number of 99495796. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 13, 2025. This trademark is owned by PharmaResearch Co., Ltd.. The NADOX trademark is filed in the Pharmaceutical Products category with the following description:
Antibiotic preparations relating to doxorubicin; chemotherapeutics relating to doxorubicin; pharmaceutical preparations for the treatment of tumours relating to doxorubicin; pharmaceutical preparations for chemical disorder treatment relating to doxorubicin; pharmaceutical agents affecting sensory organs relating to doxorubicin; pharmaceutical agents affecting metabolism relating to doxorubicin; pharmaceutical agents affecting peripheral nervous system relating to doxorubicin; cardiovascular pharmaceutical preparations relating to doxorubicin; pharmaceutical preparations and compositions for the treatment and prevention of cancer relating to doxorubicin; pharmaceutical preparations and substances for the prevention of cancer relating to doxorubicin; biopharmaceuticals for the treatment of cancer relating to doxorubicin; biological preparations for the treatment of cancer relating to doxorubicin; pharmaceutical preparations for the treatment of cancer relating to doxorubicin; compounds ...
